Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2025

Mar 18, 2025

31996_dirs_2025-03-18_f14af28b-d99c-4a95-ada3-5667e2953702.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2025-03-14

Reporting Person: Foust Warren (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-03-14 Restricted Stock Units $0 A 58651 Acquired Common Stock (58651) Direct
2025-03-14 Restricted Stock Units $0 A 29326 Acquired Common Stock (29326) Direct

Footnotes

F1: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.

F2: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with annual equity award. These RSUs vest as to 1/3 (19,550 shares) on March 14, 2026, 1/3 (19,550 shares) on March 14, 2027, and 1/3 (19,551 shares) on March 14, 2028.

F3: Reflects RSUs granted to the Reporting Person on March 14, 2025 in connection with the Reporting Person's promotion to President and Chief Operating Officer. These RSUs vest as to 1/3 (9,775 shares) on March 14, 2026, 1/3 (9,775 shares) on March 14, 2027, and 1/3 (9,776 shares) on March 14, 2028.